Skip to main content

Table 2 Independent predictors of all-cause mortality at 20 years of the entire study cohort

From: Bezafibrate for the treatment of dyslipidemia in patients with coronary artery disease: 20-year mortality follow-up of the BIP randomized control trial

 

HR

95 % CI

P value

Lower

Upper

Fibrate treatment

0.90

0.82

0.98

0.026

Past MI

1.45

1.30

1.64

<0.001

Glucose (per 1 mg/dl)

1.01

1.005

1.01

<0.001

Age (per year increment)

1.09

1.08

1.10

<0.001

BMI (per unit)

1.03

1.01

1.04

<0.001

NYHA functional class ≥ II

1.13

1.04

1.22

0.005

TG ≥200 mg/dl

1.04

0.92

1.18

0.52

Diabetes mellitus

1.34

1.14

1.58

<0.001

  1. Model further adjusted for hypertension, gender, baseline HDL and use of non-study lipid lowering medication as a time dependent covariate